Clinical Trial Update: Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With Expanded Programme on Immunization Vaccines [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating safety and immunogenicity of administering EV71 vaccine concomitantly with Expanded Programme on Immunization vaccines.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand Foot and Mouth Disease

Drugs mentioned

• EV71 vaccine (enterovirus 71 vaccine)

Snippet

Sponsor: Sinovac Biotech Co., Ltd | Conditions: Hand, Foot and Mouth Disease | Phase 4 | Status: COMPLETED